Huntington's Disease News and Research

Latest Huntington's Disease News and Research

MSC-mediated RNAi transfer holds promise for Huntington's disease

MSC-mediated RNAi transfer holds promise for Huntington's disease

20 Jan 2012
Alnylam sues Tekmira over LNP-formulated siRNA molecules

Alnylam sues Tekmira over LNP-formulated siRNA molecules

18 Jan 2012
Scientists identify compound that can help repair toxic RNA defect

Scientists identify compound that can help repair toxic RNA defect

18 Jan 2012
Disruption of circadian rhythms cause accelerated neurodegeneration and premature death

Disruption of circadian rhythms cause accelerated neurodegeneration and premature death

11 Jan 2012
Alnylam files CTA with the U.K. MHRA to initiate ALN-TTR02 Phase I trial in ATTR

Alnylam files CTA with the U.K. MHRA to initiate ALN-TTR02 Phase I trial in ATTR

7 Jan 2012
Scripps professor receives pair of notable grants to study kinesin

Scripps professor receives pair of notable grants to study kinesin

6 Jan 2012
Positive preliminary results from Alnylam's Phase I ALN-PCS trial on severe hypercholesterolemia

Positive preliminary results from Alnylam's Phase I ALN-PCS trial on severe hypercholesterolemia

5 Jan 2012
DNA stays too tightly wound in brain cells of patients with schizophrenia

DNA stays too tightly wound in brain cells of patients with schizophrenia

28 Dec 2011
UCL awarded 20M grant to establish The Leonard Wolfson Experimental Neurology Centre

UCL awarded 20M grant to establish The Leonard Wolfson Experimental Neurology Centre

19 Dec 2011
UCL to establish new center for treatment of neurodegenerative diseases

UCL to establish new center for treatment of neurodegenerative diseases

19 Dec 2011
Increased Sirt1 expression protects against neurodegeneration in HD mouse model

Increased Sirt1 expression protects against neurodegeneration in HD mouse model

19 Dec 2011
SIRT1 gene appears to delay onset of HD in mouse model

SIRT1 gene appears to delay onset of HD in mouse model

19 Dec 2011
New drug candidate may halt mental decline of Alzheimer's

New drug candidate may halt mental decline of Alzheimer's

15 Dec 2011
Dye derived from Canary Island lichens may help treat Alzheimer's disease

Dye derived from Canary Island lichens may help treat Alzheimer's disease

3 Dec 2011
Einstein, Montefiore receive NINDS grant to establish clinical site for NeuroNEXT

Einstein, Montefiore receive NINDS grant to establish clinical site for NeuroNEXT

2 Dec 2011
Enrollment complete in Alnylam's ALN-RSV01 Phase IIb study for RSV infection

Enrollment complete in Alnylam's ALN-RSV01 Phase IIb study for RSV infection

29 Nov 2011
Dantrolene reduces severity of walking and balance problems linked with HD

Dantrolene reduces severity of walking and balance problems linked with HD

24 Nov 2011
Carefully selected young, healthy neurons can repair brain circuitry

Carefully selected young, healthy neurons can repair brain circuitry

24 Nov 2011
Neuralstem initiates spinal cord neural stem cell trial in ALS

Neuralstem initiates spinal cord neural stem cell trial in ALS

23 Nov 2011
Positive preliminary results from Alnylam's ALN-TTR01 Phase I clinical trial for TTR-mediated amyloidosis

Positive preliminary results from Alnylam's ALN-TTR01 Phase I clinical trial for TTR-mediated amyloidosis

21 Nov 2011

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback